Target Price | $71.92 |
Price | $57.50 |
Potential |
25.08%
register free of charge
|
Number of Estimates | 13 |
13 Analysts have issued a price target Revolution Medicines Inc 2025 .
The average Revolution Medicines Inc target price is $71.92.
This is
25.08%
register free of charge
$86.00
49.57%
register free of charge
$63.00
9.57%
register free of charge
|
|
A rating was issued by 14 analysts: 14 Analysts recommend Revolution Medicines Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Revolution Medicines Inc stock has an average upside potential 2025 of
25.08%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 11.58 | 0.32 |
67.27% | 97.22% | |
EBITDA Margin | -4,126.77% | -205,367.17% |
487.26% | 4,876.46% | |
Net Margin | -5,591.67% | -183,646.66% |
282.90% | 3,184.29% |
14 Analysts have issued a sales forecast Revolution Medicines Inc 2024 . The average Revolution Medicines Inc sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Revolution Medicines Inc EBITDA forecast 2024. The average Revolution Medicines Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 Revolution Medicines Inc Analysts have issued a net profit forecast 2024. The average Revolution Medicines Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -3.86 | -3.52 |
25.32% | 8.81% | |
P/E | negative | |
EV/Sales | 25,541.63 |
9 Analysts have issued a Revolution Medicines Inc forecast for earnings per share. The average Revolution Medicines Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Revolution Medicines Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Revolution Medicines Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.